10バイアルパック在庫 520%オフTB-500 10 mg
アクチン結合の研究用ペプチド
Buy TB-500 in Australia for actin-binding research. Lab-verified, lyophilised, Australian-shipped.
研究用途専用。 本化合物は体外研究および実験室用途に限り販売され、人体への摂取や治療目的での使用を意図していません。ご購入をもって、適格な研究者であること、および当社の 免責事項全文に同意したものとみなします。
残り5パック
チモシンβ-4 断片。細胞遊走、アクチン調節、組織リモデリングにおける役割が研究用途で検討されています。
TB-500 is a synthetic peptide fragment of the naturally occurring protein thymosin β-4. The molecule contains the active actin-binding domain of full-length thymosin β-4 and has been extensively studied for its role in cell migration, wound-healing models, and tissue regeneration pathways. Quantum Labs supplies TB-500 as a lyophilised powder in sealed vials for Australian research applications.
TB-500 is most often studied alongside BPC-157 in tissue-repair research, where the two compounds target complementary mechanisms — BPC-157 acting predominantly through nitric oxide and VEGF pathways, TB-500 acting on actin sequestration and cytoskeletal remodelling. Our BPC-157 + TB-500 research stack supplies both compounds in pre-portioned vials.
Material ships from Australian stock, HPLC-verified to ≥99% purity with batch-level certificates of analysis available on request.
作用機序
G-actin への結合と細胞遊走マーカーへの影響が検討されています。研究では、組織修復経路への潜在的な有用性が示唆されています。
純度規格 ≥99% に対して HPLC で検証。認定された第三者ラボが独立して試験しています。
Mechanism in research literature
TB-500 contains the LKKTETQ actin-binding sequence from thymosin β-4. In research models, this peptide region has been shown to modulate actin polymerisation, promote endothelial cell migration, and influence the differentiation of mesenchymal stem cells toward repair phenotypes. The full mechanism is still under investigation in pre-clinical literature.
TB-500 — よくある質問
What is TB-500?
TB-500 is a synthetic fragment of the naturally occurring protein thymosin β-4, containing the active actin-binding domain. It is supplied for laboratory research into cell-migration and tissue-repair pathways.
Is TB-500 legal in Australia?
TB-500 is restricted for compounded human therapeutic supply in Australia. Research-grade TB-500 supplied without therapeutic representation remains available for laboratory use. Quantum Labs supplies TB-500 for research use only.
What is the typical TB-500 research dosage?
Published animal studies have used TB-500 doses in the 2-10 mg/kg range for systemic models. Human therapeutic dosing is not established. Researchers should reference primary literature for protocol-specific dosing.
Can TB-500 be used with BPC-157?
Combined BPC-157 + TB-500 protocols are common in tissue-repair research. The two compounds are believed to act on complementary pathways — BPC-157 on nitric oxide and VEGF, TB-500 on actin and cell migration. Quantum Labs supplies a BPC-157 + TB-500 research stack in pre-portioned vials.
What's the difference between TB-500 and thymosin β-4?
Full-length thymosin β-4 is a 43-amino-acid endogenous protein. TB-500 is the shorter active fragment containing the LKKTETQ actin-binding sequence. The shorter fragment is more practical for research-grade synthesis and is the form most studied in pre-clinical tissue-repair literature.
How is TB-500 stored?
Lyophilised TB-500 is stable at 2-8°C in unopened sealed vials. Once reconstituted, the working solution is typically stored at 2-8°C and used within 30 days. Avoid freeze-thaw cycles.
TB-500 に関連するガイド
研究者はこちらも閲覧しています
おすすめ10バイアルパック22%オフCJC-1295 + Ipamorelin
凍結乾燥粉末5 mg + 5 mg
古典的 GHRH + グレリン模倣スタック
2 件のスタックに収録
10バイアルパック82%オフBPC-157
凍結乾燥粉末5 mg · 3 strengths
組織修復の研究用ペプチド